- Home
- BODI vs CBUS Comparison
BODI vs CBUS Comparison
Compare BODI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BODI | CBUS |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Agricultural Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 69.9M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | BODI | CBUS |
|---|---|---|
| Price | $11.21 | $1.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.00 | ★ $20.00 |
| AVG Volume (30 Days) | 104.0K | ★ 175.3K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $282,565,000.00 | $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.38 | $1.09 |
| 52 Week High | $12.33 | $4.24 |
Technical Indicators
Market Signals| Indicator | BODI | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 63.90 | 52.77 |
| Support Level | $10.18 | $1.49 |
| Resistance Level | $12.33 | $1.75 |
| Average True Range (ATR) | 0.99 | 0.14 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 69.21 | 50.00 |
Price Performance
Historical ComparisonAbout BODI The Beachbody Company Inc.
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.